CN101991648A - Traditional Chinese medicine for treating diabetic coronary heart disease - Google Patents

Traditional Chinese medicine for treating diabetic coronary heart disease Download PDF

Info

Publication number
CN101991648A
CN101991648A CN2010105429119A CN201010542911A CN101991648A CN 101991648 A CN101991648 A CN 101991648A CN 2010105429119 A CN2010105429119 A CN 2010105429119A CN 201010542911 A CN201010542911 A CN 201010542911A CN 101991648 A CN101991648 A CN 101991648A
Authority
CN
China
Prior art keywords
chinese medicine
heart disease
radix
coronary heart
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105429119A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2010105429119A priority Critical patent/CN101991648A/en
Publication of CN101991648A publication Critical patent/CN101991648A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating the diabetic coronary heart disease, belonging to the field of traditional Chinese medicines for treating diabetes and achieving the aim of good and quick effect. The traditional Chinese medicine for treating the diabetic coronary heart disease is prepared from the following raw materials of radix glehniae, angelica, pseudo-ginseng, cynanchum atratum, glossy ganoderma, the root of red-rooted salvia, and the like. The invention has the effects of strengthening body resistance and culturing essence, enriching qi, nourishing blood, nourishing yin, clearing away heat and activating blood circulation to dissipate blood stasis and has the advantages of remarkable effect, accurate pharmaceutical effect and rapider effect.

Description

A kind of Chinese medicine for the treatment of diabetic coronary heart disease
Technical field
The invention belongs to the field of Chinese medicines of treatment diabetes.
Background technology
Diabetic coronary heart disease is meant the coronary heart disease that diabetics is concurrent, is due to the cardiovascular injuries pathological changes and neuropathy that is taken place on the basis of metabolism disorders such as sugar, fat.Being the diabetes most common complication, also is the main cause of death of diabetics.According to statistics, diabetics 70% is died from diabetic coronary heart disease.The present Chinese medicine aspect that is intended to treat diabetic coronary heart disease, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many diabetic coronary heart disease patients stand the torment of feeling of oppression and pain in the chest, cardiopalmus agitation for a long time owing to can not get the treatment of active drug, face the danger of myocardial infarction, patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of diabetic coronary heart disease, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of diabetic coronary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Glehniae 5-15 part Radix Angelicae Sinensis 6-18 part Radix Notoginseng 3-9 part
Radix Cynanchi Atrati 5-15 part Ganoderma 6-18 part Radix Salviae Miltiorrhizae 6-18 part
The Chinese medicine of this treatment diabetic coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hour, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with 1: 20 hot water (95 ℃) lixiviate → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Radix Glehniae, Radix Angelicae Sinensis, Radix Cynanchi Atrati, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think in research, the general hypoimmunity of diabetics, and this disease is many by diabetes with the passing of time, scorching yin-damaging and Qi consuming, deficiency of both QI and YIN is due to the heart arteries and veins stasis of blood hinders.Morbific all multifactor in, hypoimmunity is the very corn of a subject and key.So the present invention attaches most importance to enhancing immunity, benefiting QI and nourishing blood, replenishing YIN and removing heat, blood circulation promoting and blood stasis dispelling is obtained good efficacy.At present, the Western medicine and the Chinese medicine of multiple treatment heart disease, coronary heart disease being arranged on the China market---the advantage of nitroglycerin, SUXIAO JIUXIN WAN is emergency when chest pain unexpected generation uncomfortable in chest, allows the patient avoid myocardial infarction; The advantage of Isosorbide fat sheet, Radix Salviae Miltiorrhizae drop pill is in 8~12 hours time, control chest pain slight generation uncomfortable in chest or not generation; And the advantage of Chinese medicine of the present invention is fundamentally to improve blood supply of cardiac muscle, allow chest pain uncomfortable in chest be not within 12 hours but in the long time, gradually reduce, alleviate, until not taking place.We can say that the present invention compares with above-mentioned four kinds of above the ordinary Chinese medicine and western medicine, the former stresses to control " mark ", and this medicine stresses to control " basis ", is each have their own advantage, each have their own purposes.Thus, this patient is many a kind of better optimize therapeutic scheme---" 1+1+1 ", promptly uses nitroglycerin (SUXIAO JIUXIN WAN) " emergency "; Do not show effect in 12 hours with Isosorbide fat sheet (Radix Salviae Miltiorrhizae drop pill) control; Reduce chest pain generation uncomfortable in chest with the present invention.Value of the present invention that Here it is.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, tranquilizing by nourishing the heart, enhancing human body immunity power, " removing " effect of immunity makes blood clean, and is no longer sticky, but rich mobile, this is the basis of improving blood supply of cardiac muscle; Radix Salviae Miltiorrhizae, pseudo-ginseng blood-circulation-invigovating are promoted blood circulation, blood-activating analgetic, and Ganoderma, Radix Angelicae Sinensis and Radix Salviae Miltiorrhizae, Radix Notoginseng are share, the prosperous hemapodium of gas, tissue regeneration promoting blood and blood stasis removing blood, " reparation " effect of immunity, softening arteria coronaria blood vessel reduces stasis of blood resistance, makes blood supply of cardiac muscle full; Be aided with the sweet cold lung moistening of Radix Glehniae, nourishing YIN and clearing away heat; The Radix Cynanchi Atrati heat clearing away, diuresis, the moon that nourishes heart is grown conception vessel.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, replenishing YIN and removing heat, the merit of blood circulation promoting and blood stasis dispelling.Make a general survey of full side, the merit of existing element culturing fixed folder does not have the numbness that consumes impairment of QI the moon again, and residence is mended in logical, the good recipe that nourishes heart really and promote blood circulation.Effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Glehniae 60 gram Radix Angelicae Sinensis 70 gram Radix Notoginseng 30 grams
Radix Cynanchi Atrati 60 kairine sesames 70 gram Radix Salviae Miltiorrhizaes 70 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Radix Glehniae, Radix Angelicae Sinensis, Radix Cynanchi Atrati, Radix Salviae Miltiorrhizae are extracted, make extract fine powder 66 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 342 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Glehniae 100 gram Radix Angelicae Sinensis 120 gram Radix Notoginseng 60 grams
Radix Cynanchi Atrati 100 kairine sesames 120 gram Radix Salviae Miltiorrhizaes 120 grams
By above-mentioned same method, make 614 of Chinese medicinal capsules, close Chinese medicine fine powder and extract 0.28 gram in every capsules.
3, get following prescription (weight is unit by gram):
Radix Glehniae 150 gram Radix Angelicae Sinensis 180 gram Radix Notoginseng 90 grams
Radix Cynanchi Atrati 150 kairine sesames 180 gram Radix Salviae Miltiorrhizaes 180 grams
By above-mentioned same method, make 921 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
4 parts of 9 portions of Radix Notoginseng of 8 parts of Radix Angelicae Sinensis of Radix Glehniae
9 parts of 9 parts of Radix Salviae Miltiorrhizaes of 8 portions of Ganodermas of Radix Cynanchi Atrati
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
7 parts of 15 portions of Radix Notoginseng of 12 parts of Radix Angelicae Sinensis of Radix Glehniae
15 parts of 15 parts of Radix Salviae Miltiorrhizaes of 12 portions of Ganodermas of Radix Cynanchi Atrati
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic coronary heart disease, through 7 routine clinical observations.Selecting the tcm diagnosis diabetic coronary heart disease is standard: diabetics has the inclination to distinguish malaise symptoms in work, excited, heavy meal or when catching cold the back---cardiopalmus agitation, limb soft weak, chest pain is uncomfortable in chest, dyspnea, have a rest or take nitroglycerin after alleviate.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 3 examples, women's 4 examples do not have other serious disease, and the age is 47 years old-81 years old, 63.7 years old mean age.
Efficacy determination:
1, produce effects: diabetics is equal under the batten spare cardiac distress symptom and obviously alleviates in work, excited, heavy meal or after catching cold---and the cardiopalmus agitation alleviates, and tachycardia disappears, pulse 60~90 times/minute; The soft weak alleviation of limb, on one's body energetically; Chest pain obvious improvement uncomfortable in chest, attack times reduces, and degree alleviates; Breathe smooth and easyly, heart district is comfortable; The visible blood supply of cardiac muscle of electrocardiogram improves.
2, effective: cardiac distresses such as cardiopalmus agitation, chest pain are uncomfortable in chest, dyspnea are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, except that the antidiabetic drug that diabetics is necessary is taken (medicine is constant, amount is constant) as usual, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 3 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.

Claims (1)

1. Chinese medicine for the treatment of diabetic coronary heart disease, it is characterized in that: it is to make with the component of following weight ratio: Radix Glehniae 5-15 part, Radix Angelicae Sinensis 6-18 part, Radix Notoginseng 3-9 part, Radix Cynanchi Atrati 5-15 part, Ganoderma 6-18 part, Radix Salviae Miltiorrhizae 6-18 part.
CN2010105429119A 2010-11-11 2010-11-11 Traditional Chinese medicine for treating diabetic coronary heart disease Pending CN101991648A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105429119A CN101991648A (en) 2010-11-11 2010-11-11 Traditional Chinese medicine for treating diabetic coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105429119A CN101991648A (en) 2010-11-11 2010-11-11 Traditional Chinese medicine for treating diabetic coronary heart disease

Publications (1)

Publication Number Publication Date
CN101991648A true CN101991648A (en) 2011-03-30

Family

ID=43782725

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105429119A Pending CN101991648A (en) 2010-11-11 2010-11-11 Traditional Chinese medicine for treating diabetic coronary heart disease

Country Status (1)

Country Link
CN (1) CN101991648A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105193995A (en) * 2015-11-02 2015-12-30 张希富 Quick-acting traditional Chinese medicine granules for treating heart diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105193995A (en) * 2015-11-02 2015-12-30 张希富 Quick-acting traditional Chinese medicine granules for treating heart diseases

Similar Documents

Publication Publication Date Title
CN102380032A (en) Traditional Chinese medicine for treating diabetic heart disease
CN101554470A (en) Traditional Chinese medicine for treating tachycardia
CN102389493A (en) Traditional Chinese medicine for treating diabetic heart disease
CN102172378A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN101991648A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN102389494A (en) Chinese medicine for treating diabetic heart diseases
CN101983640A (en) Traditional Chinese medicine for treating diabetic heart disease
CN101991743A (en) Traditional Chinese medicine for treating diabetic heart disease
CN101991647A (en) Traditional Chinese medicine for treating diabetic coronary heart diseases
CN102091229A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN101972327A (en) Traditional Chinese medicine for treating diabetic heart disease
CN101843755A (en) Chinese medicament for treating diabetic cardiopathy
CN101843807A (en) Chinese medicament for treating diabetic cardiopathy
CN101843660A (en) Chinese medicament for treating tachycardia
CN102138974A (en) Traditional Chinese medicine for treating diabetic cardiopathy
CN102172367A (en) Traditional Chinese medicine for treating diabetic heart disease
CN102188482A (en) Chinese medicine for treating diabetic heart diseases
CN102114178A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN101979049A (en) Chinese medicament for treating diabetic coronary heart disease
CN102091126A (en) Traditional Chinese medicine for treating diabetic heart disease
CN101961410A (en) Chinese medicament for treating diabetic heart disease
CN102114141A (en) Traditional Chinese medicine for treating diabetic cardiopathy
CN101983638A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN102139044A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN102114087A (en) Traditional Chinese medicine for treating diabetic coronary heart disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110330